Feb 27, 2025 8:30am EST FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic
Feb 05, 2025 9:15am EST FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
Nov 19, 2024 9:15am EST FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
Nov 14, 2024 9:15am EST FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
Nov 12, 2024 4:20pm EST FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Oct 29, 2024 9:15am EDT FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
Oct 28, 2024 9:31am EDT FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
Oct 18, 2024 8:30am EDT FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases